Foresite Capital Management VI LLC
18 holdingsFiling period: 2026-03-31Current AUM: $546.1Mestimated from latest prices
| # | Ticker | Company | Shares | Reported Value | Current Value | % Portfolio | Change | Date |
|---|---|---|---|---|---|---|---|---|
| 1 | CGON | CG Oncology, Inc. | 2.22M | $150.3M | $158.1M | 28.96% | -- | 2026-03-31 |
| 2 | ALMS | ALUMIS INC. | 4.25M | $93.6M | $120.0M | 21.97% | -- | 2026-03-31 |
| 3 | CNTA | Centessa Pharmaceuticals plc | 1.36M | $54.2M | $54.2M | 9.92% | -- | 2026-03-31 |
| 4 | CRVS | Corvus Pharmaceuticals, Inc. | 1.83M | $26.8M | $24.3M | 4.45% | +450.0K | 2026-03-31 |
| 5 | DNLI | Denali Therapeutics Inc. | 1.21M | $23.2M | $27.9M | 5.10% | +210.0K | 2026-03-31 |
| 6 | AGIO | AGIOS PHARMACEUTICALS, INC. | 525.0K | $17.8M | $15.8M | 2.89% | -5,000 | 2026-03-31 |
| 7 | VSTM | Verastem, Inc. | 3.15M | $16.7M | $18.3M | 3.34% | +11.5K | 2026-03-31 |
| 8 | KYMR | Kymera Therapeutics, Inc. | 146.3K | $12.2M | $15.1M | 2.77% | -- | 2026-03-31 |
| 9 | NERV | Minerva Neurosciences, Inc. | 1.99M | $12.0M | $7.9M | 1.45% | -- | 2026-03-31 |
| 10 | CLDX | Celldex Therapeutics, Inc. | 315.9K | $10.0M | $12.0M | 2.20% | -- | 2026-03-31 |
| 11 | ATAI | AtaiBeckley Inc. | 2.75M | $9.7M | $19.7M | 3.62% | -- | 2026-03-31 |
| 12 | ATAI | AtaiBeckley Inc. | 2.75M | $9.7M | $19.7M | 3.62% | -- | 2026-03-31 |
| 13 | HNGE | Hinge Health, Inc. | 220.4K | $8.5M | $16.5M | 3.01% | +85.4K | 2026-03-31 |
| 14 | CRNX | Crinetics Pharmaceuticals, Inc. | 212.0K | $7.7M | $17.7M | 3.24% | -- | 2026-03-31 |
| 15 | OKUR | OnKure Therapeutics, Inc. | 1.45M | $6.0M | $5.5M | 1.01% | -- | 2026-03-31 |
| 16 | JBIO | Jade Biosciences, Inc. | 320.0K | $4.5M | $6.3M | 1.16% | -- | 2026-03-31 |
| 17 | — | GH Research PLC | 315.5K | $4.4M | $4.4M | 0.81% | -- | 2026-03-31 |
| 18 | — | Zura Bio Ltd | 450.0K | $2.7M | $2.7M | 0.49% | -- | 2026-03-31 |
← Scroll →